approval
saveEPYSQLI (ECULIZUMAB-AAGH) — FDA approval
community read0 votes
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTION. Route: SOLUTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 23, 2026 · 254d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 28, 2025 · 310d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 10, 2025 · 328d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalApr 30, 2025 · 522d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalMar 12, 2025 · 571d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 28, 2025 · 614d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 21, 2025 · 621d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 15, 2024 · 688d ago
same company · ±60 days · 5
- approvalOPUVIZ: OPUVIZ (AFLIBERCEPT-YSZY) — FDA approvalAug 25, 2025
- approvalBYOOVIZ: BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approvalAug 15, 2025
- approvalHADLIMA: HADLIMA (ADALIMUMAB-BWWD) — FDA approvalOct 17, 2025
- approvalinfliximab biosimilar: RENFLEXIS (INFLIXIMAB-ABDA) — FDA approvalOct 28, 2025
- approvaldenosumab biosimilar: DENOSUMAB-DSSB — FDA approvalOct 29, 2025
comments(0)
5-min edit window · permanent after that